Cardiotoxic Effects and the Influence on the β‐Adrenoceptor Function of Doxorubicin (Adriamycin®) in the Rat

Abstract
The possible relationship between the effect of the anthracycline-cytostatic doxorubicin (Dox) on the cardiac .beta.-adrenoceptor function in vitro and the development of delayed cardiotoxicity in vivo has been investigated in the rat. Dox (10-5-10-4M) blocked the chronotropic effect of isoprenaline on isolated atria in a competitive manner. Treatment with a single dose of Dox 5 mg/kg intravenously caused marked ECG changes manifested by progressive prolongations of the Q.alpha.T and S.alpha.T-intervals, which amounted to 37% and 58% respectivity 5 weeks after the medication. At this time no .beta.-blocking action was detectable when tested on the isolated atria in the same rats. The results indicate that the delayed cardiotoxicity induced by Dox is not mediated by an interference with the cardiac .beta.-adrenoceptor function.